TY - JOUR
T1 - Surface plasmon-enhanced fluorescence immunosensor for monitoring cardiac troponin I
AU - Toma, Koji
AU - Oishi, Koki
AU - Iitani, Kenta
AU - Arakawa, Takahiro
AU - Mitsubayashi, Kohji
N1 - Funding Information:
We appreciate Dr. Hiromi Yatsuda and Mr. Naoki Yoshimura for SAW devices. This work was partly supported by Japan Society for the Promotion of Science (JSPS, Japan) KAKENHI Grant Number JP 16K18112 and 26889025 ; the Precise Measurement Technology Promotion Foundation (PMTP-F, Japan); the Ministry of Education, Culture, Sports, Science and Technology (MEXT, Japan) Special Funds for “Cooperative Research Project of Research Center for Biomedical Engineering”.
Publisher Copyright:
© 2022
PY - 2022/10/1
Y1 - 2022/10/1
N2 - Perioperative myocardial infarction (PMI) is a common complication of non-cardiac surgery and monitoring a PMI marker, cardiac troponin I (cTnI), is helpful for the early detection of PMI. However, there is no existing biosensor for continuous measurement of cTnI. Addressing this challenge, we developed a surface plasmon-enhanced fluorescence (SPF) immunosensor for the semi-continuous measurement of cTnI. The sensor system relied on attenuated total reflection with Kretschmann configuration at the wavelength of 633 nm. An Au substrate was modified with a robust scaffold protein fused with protein G that enabled immobilization and repeated use of a capture antibody. The cTnI was measured by a sandwich assay with a fluoresce-labeled detection antibody. We also fabricated a light pipe flow-cell to collect the fluorescence efficiently. As a result, the dynamic range of the SPF immunosensor to cTnI was 3.9–100 ng/mL, and the LOD was 0.98 ng/mL. The sensor showed output only from samples containing cTnI, indicating the high selectivity. The sensor surface was regenerated by glycine-HCl (pH 2) solution, and the high reproducibility of the output (C.V. = 1.8%) was obtained in five repeated measurements of cTnI. These results indicated the potential of the SPF immunosensor for cTnI monitoring.
AB - Perioperative myocardial infarction (PMI) is a common complication of non-cardiac surgery and monitoring a PMI marker, cardiac troponin I (cTnI), is helpful for the early detection of PMI. However, there is no existing biosensor for continuous measurement of cTnI. Addressing this challenge, we developed a surface plasmon-enhanced fluorescence (SPF) immunosensor for the semi-continuous measurement of cTnI. The sensor system relied on attenuated total reflection with Kretschmann configuration at the wavelength of 633 nm. An Au substrate was modified with a robust scaffold protein fused with protein G that enabled immobilization and repeated use of a capture antibody. The cTnI was measured by a sandwich assay with a fluoresce-labeled detection antibody. We also fabricated a light pipe flow-cell to collect the fluorescence efficiently. As a result, the dynamic range of the SPF immunosensor to cTnI was 3.9–100 ng/mL, and the LOD was 0.98 ng/mL. The sensor showed output only from samples containing cTnI, indicating the high selectivity. The sensor surface was regenerated by glycine-HCl (pH 2) solution, and the high reproducibility of the output (C.V. = 1.8%) was obtained in five repeated measurements of cTnI. These results indicated the potential of the SPF immunosensor for cTnI monitoring.
KW - Cardiac troponin
KW - Immunosensor
KW - Monitoring
KW - Myocardial infarction
KW - Surface plasmon-enhanced fluorescence
UR - http://www.scopus.com/inward/record.url?scp=85131434788&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131434788&partnerID=8YFLogxK
U2 - 10.1016/j.snb.2022.132132
DO - 10.1016/j.snb.2022.132132
M3 - Article
AN - SCOPUS:85131434788
SN - 0925-4005
VL - 368
JO - Sensors and Actuators B: Chemical
JF - Sensors and Actuators B: Chemical
M1 - 132132
ER -